These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25348560)

  • 21. Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
    Adlan AM; Lip GY
    Drug Saf; 2013 Feb; 36(2):93-110. PubMed ID: 23329540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
    Schweizer PA; Becker R; Katus HA; Thomas D
    Drug Des Devel Ther; 2011 Jan; 5():27-39. PubMed ID: 21267357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS.
    Naccarelli GV; Kowey PR
    Curr Cardiol Rev; 2014 Nov; 10(4):303-8. PubMed ID: 24821656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone -- waxed and waned and waxed again.
    Doggrell SA
    Expert Opin Pharmacother; 2001 Nov; 2(11):1877-90. PubMed ID: 11825323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone and dronedarone: An update.
    Vamos M; Hohnloser SH
    Trends Cardiovasc Med; 2016 Oct; 26(7):597-602. PubMed ID: 27155812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN; Mody FV; Lopez B; Sarma JS
    Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias.
    Hermida JS; Tcheng E; Jarry G; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C
    Europace; 2004 Mar; 6(2):169-74. PubMed ID: 15018878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure.
    Weinfeld MS; Drazner MH; Stevenson WG; Stevenson LW
    J Heart Lung Transplant; 2000 Jul; 19(7):638-43. PubMed ID: 10930812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Amiodarone and the thyroid].
    Brescia L; Benoit A; Betea D; Delvenne P; Hamoir E; Beckers A
    Rev Med Liege; 2014 Oct; 69(10):549-54. PubMed ID: 25796749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amiodarone: treatment or cause of atrial fibrillation?].
    Allali G; Falconnet C
    Rev Med Suisse; 2005 Nov; 1(39):2533-5. PubMed ID: 16323735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy.
    Singh BN
    Clin Cardiol; 1997 Jul; 20(7):608-18. PubMed ID: 9220176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow granulomas possibly associated with amiodarone.
    Yamreudeewong W; McIntyre WW; Sun TJ; Ranelli PL
    Pharmacotherapy; 2000 Jul; 20(7):855-9. PubMed ID: 10907978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
    Singh BN
    Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
    Irimie A; Piciu D
    Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.